Marketfy
Financial Data & APIs
Events
Premarket Prep
Membership is Free
What are you waiting for? Sign up now!
Name:
Username available!
Username taken!
Email:
Email available!
Email taken!
Password:
Leave blank:
OR
Free Account Login
Click here to access your premium account
Username or email:
Password:
OR
Forgot password?
Contribute
Login
Join
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Retail Sales
Offerings
IPOs
Insider Trades
Biotech/FDA
Freight
Tech
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
Global Economics
Previews
Reviews
Small-Cap
Cryptocurrency
Penny Stocks
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Catalyst
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Education
Education News
Forex Trading
InFOCUS Newsletter
Online Investing
Options Trading
Practice Simulator
Fintech
Investing
Best Online Brokers
Personal Finance
Compare Brokers
Ally Invest Review
Binary Options Review
eOption
Etrade Review
Forex.com Review
Interactive Brokers Review
Personal Capital Review
Suretrader Review
TD Ameritrade Review
Tradestation Review
Yewno|Edge Review
Cannabis
Premium
Market Overview
Tickers
Articles
Keywords
Search by keyword...
googlecse
WANT TO CATCH
PTX
NEWS
BEFORE
IT CHANGES THE STOCK PRICE?
More From
Summary
Ideas
Twitter ($)
All News
Analyst Coverage
Analyst Ratings
News Coverage
News
General
Contracts
Dividend Summaries
Dividend Calendar
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Press Releases
Earnings
Earning Summaries
Earnings Calendar
Guidance Summaries
Pernix Therapeutics Holdings, Inc.
:
Add to Watchlist +
Trade
{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists
Sector:
Industry:
0.0000
0 (%)
Data as of Dec 16, 2019
Prev. Close
Price Open
Volume
0
Day's Range
-
52 Wk Range
-
50 Day Moving Avg.
PE Ratio
Shares Outstanding
Market Cap
Trade PTX stock with
recommended broker Ally Invest
. Commissions as low as $3.95.
1d
5d
1m
3m
1y
5y
YTD
Analyst Rating
View All Ratings
Date
Research Firm
Action
Current
Target
8/12/16
Brean Capital
Downgrades
Buy
Hold
3/17/16
Oppenheimer
Downgrades
Outperform
Perform
3/11/16
Brean Capital
Maintains
Buy
5.0
Headlines
Press Releases
The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings
Shanthi Rexaline
Tue, 05 Mar 2019 07:24:27 -0500
81 Biggest Movers From Friday
Lisa Levin
Mon, 04 Mar 2019 05:39:48 -0500
64 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Fri, 01 Mar 2019 13:18:25 -0500
Pernix Therapeutics shares are trading lower on continued weakness after the company late Wednesday announced it has filed voluntary petitions commencing cases under Chapter 11 bankruptcy.
Benzinga Newsdesk
Fri, 01 Mar 2019 13:09:22 -0500
Pernix Therapeutics shares down below the $0.30 following news late Wednesday the company began proceedings for voluntary Chapter 11 bankrtupcy.
Benzinga Newsdesk
Thu, 28 Feb 2019 09:31:31 -0500
Pernix Therapeutics 8-K From Late Wed., Showed Co. Filed Voluntary Petitions Commencing Cases Under Chapter 11 Of Title 11 In Bankruptcy Court
Benzinga Newsdesk
Thu, 28 Feb 2019 09:30:51 -0500
Top 15 Most-Volatile Stocks For Thurs., Feb. 21, 2019 Via Benzinga's Securities Lending Volatility Index Powered By Tidal Markets
Benzinga Newsdesk
Thu, 21 Feb 2019 10:25:53 -0500
71 Biggest Movers From Yesterday
Lisa Levin
Wed, 20 Feb 2019 04:49:02 -0500
Mid-Afternoon Market Update: Jeld-Wen Rises On Earnings Beat; Pernix Therapeutics Shares Tumble
Lisa Levin
Tue, 19 Feb 2019 14:24:37 -0500
54 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Tue, 19 Feb 2019 13:01:54 -0500
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management
Globe Newswire
Feb 19, 2019
Detailed Research: Economic Perspectives on Pernix Therapeutics, Hallador Energy, Vince Holding, Tuesday Morning, Information Services Group, and Sienna Biopharmaceuticals — What Drives Growth in Today's Competitive Landscape
Globe Newswire
Nov 13, 2018
Pernix® Therapeutics Reports Third Quarter 2018 Financial Results
Globe Newswire
Nov 08, 2018
Pernix Therapeutics to Report Third Quarter 2018 Financial Results on Thursday, November 8
Globe Newswire
Nov 02, 2018
Pernix Therapeutics to Report Third Quarter 2018 Financial Results on Thursday, November 8
Globe Newswire
Nov 02, 2018
Pernix Therapeutics Holdings, Inc.'s Subsidiaries File Notice of Appeal in Patent Litigation Concerning Zohydro® ER with BeadTek®
Globe Newswire
Sep 12, 2018
Pernix Therapeutics Announces Ruling in Patent Litigation Concerning Zohydro® ER with BeadTek®
Globe Newswire
Aug 27, 2018
Pernix Therapeutics Reports Second Quarter 2018 Financial Results
Globe Newswire
Aug 09, 2018
Pernix Therapeutics Announces a Series of Transactions to Strengthen Its Balance Sheet and Improve Financial Flexibility
Globe Newswire
Aug 01, 2018
Pernix Therapeutics to Report Second Quarter 2018 Financial Results on Thursday, August 9
Globe Newswire
Jul 31, 2018
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
Partner Headlines
Bargain hunters drive Pernix up 47%
Seeking Alpha
Feb 21, 2019
Microcaps dominate midday movers
Seeking Alpha
Feb 19, 2019
CHF Solutions and MediciNova among healthcare gainers; Pernix Therapeutics leads the losers
Seeking Alpha
Feb 19, 2019
Pernix files for bankruptcy; shares down 65%
Seeking Alpha
Feb 19, 2019
UNIT and HIMX among premarket losers
Seeking Alpha
Feb 19, 2019
Midday movers and shakers
Seeking Alpha
Feb 15, 2019
Conformis and Avadel Pharmaceuticals among healthcare gainers; Achaogen leads the losers
Seeking Alpha
Feb 15, 2019
Pernix Therapeutics: It Seems A Serious Sell
Seeking Alpha
Feb 14, 2019
SIX, MTFB and NTAP among premarket losers
Seeking Alpha
Feb 14, 2019
GRPN, MDR, DBD and PTX among notable midday movers
Seeking Alpha
Feb 13, 2019
{{ story.title }}
{{ story.author }}
{{ story.created }}
Show more
Loading articles...
News Sentiment
Powered by StockSnips
Now:
Bullish
100% Positive
Earnings
View Earnings
Q3 2018
EST
Actual
Surprise
EPS:
Expected
2018-11-08
Rev:
EST
Actual
Surprise
EPS:
Expected
Rev:
Brokerage Center
Compare All Online Brokerages
Book A Demo
Learn How You Can Succeed In The
Market With Benzinga Pro
Fastest Market News
Real-Time News Alerts
Customizable News Filters
Book A Demo